Pastel BioScience
Developer of a proteomics biomarker discovery and validation platform that combines engineered scaffold-based affinity reagents, automated binder-selection workflows, microfluidics, surface-chemistry assays, multi-modal detection hardware and bioinformatics to enable high-sensitivity, highly multiplexed protein detection and identification. Activities include capture-molecule engineering and library selection, computational proteome fingerprinting, prototype instrument/platform development, curated proteomics resource curation, and early-stage commercialization and partnership work. The platform is positioned for applications including biomarker discovery, translational diagnostics and detection of emerging or engineered biological agents.
Industries
Nr. of Employees
small (1-50)
Pastel BioScience
Pastel BioScience Limited, The Sussex Innovation Centre, Science Park Square, Falmer, Brighton, BN1 9SB, United Kingdom
Products
Proteomics biomarker discovery and validation platform (instrument and software)
A combined platform pairing multiplexed capture-molecule arrays, automated microfluidic workflows, multi-modal detection hardware and bioinformatics to detect, identify and quantify large numbers of proteins with high sensitivity for research and translational applications.
Proteomics biomarker discovery and validation platform (instrument and software)
A combined platform pairing multiplexed capture-molecule arrays, automated microfluidic workflows, multi-modal detection hardware and bioinformatics to detect, identify and quantify large numbers of proteins with high sensitivity for research and translational applications.
Services
Collaborative development and potential out-licensing of engineered capture reagents, high-throughput selection platforms and instrument interfaces to diagnostics, instrument manufacturers and pharmaceutical partners.
Collaborative development and potential out-licensing of engineered capture reagents, high-throughput selection platforms and instrument interfaces to diagnostics, instrument manufacturers and pharmaceutical partners.
Expertise Areas
- Proteomics platform development
- Affinity reagent engineering and selection
- Automated microfluidic selection for binder discovery
- Bioinformatics for proteome fingerprinting and database integration
Key Technologies
- Microfluidics
- Surface chemistry for affinity capture
- Optical fluorescence detection
- Electronic chip/FET detection
News & Updates
Industry article describing the company's work to combine engineered protein capture agents with high-throughput detection approaches to access the human proteome.
Blog post highlighting a proteomics resources list provided by the company.
Case study describing the company's objective to develop epimer technology as a replacement for antibody technology and its potential applications across diagnostics, therapeutics and proteomics.
Received a proof-of-concept grant to support demonstration of single-molecule detection and identification of target proteins as part of platform development.
Announced an informal collaboration with an external diagnostics company to advance development of the protein biomarker discovery and validation platform toward commercial realisation.
Announcement of commencement of research and development activities hosted within university laboratory facilities.
Industry article describing the company's work to combine engineered protein capture agents with high-throughput detection approaches to access the human proteome.
Blog post highlighting a proteomics resources list provided by the company.
Case study describing the company's objective to develop epimer technology as a replacement for antibody technology and its potential applications across diagnostics, therapeutics and proteomics.
Received a proof-of-concept grant to support demonstration of single-molecule detection and identification of target proteins as part of platform development.
Announced an informal collaboration with an external diagnostics company to advance development of the protein biomarker discovery and validation platform toward commercial realisation.
Announcement of commencement of research and development activities hosted within university laboratory facilities.